Quarterly report pursuant to Section 13 or 15(d)

Significant Accounting Policies - Additional Information (Detail)

v3.8.0.1
Significant Accounting Policies - Additional Information (Detail) - USD ($)
3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Summary Of Significant Accounting Policies [Line Items]    
Research and development expense, total $ 8,721,552 $ 8,353,184
Liability for unrecognized tax benefits 0  
Interest or penalties for uncertian tax positions $ 0 $ 0
Antidilutive securities excluded from computation of earnings per share, amount 7,420,048 7,359,173
Employee Stock Purchase Plan [Member]    
Summary Of Significant Accounting Policies [Line Items]    
Common stock purchase price discount percentage 15.00%